Alejandro Estrada

His practice focuses on healthcare law, regulatory matters, compliance, and Intellectual Property, with an emphasis on Life Sciences and New Technologies. He has extensive experience handling proceedings before health authorities such as INVIMA, ICA, the Superintendence of Industry and Commerce (SIC), and the Ministry of Health. He has managed diverse portfolios of sanitary registrations and industrial property in Colombia and throughout Latin America, and has participated in complex domestic and cross-border due diligences and transactions.

• Advised one of the world’s largest e-commerce companies on the development of comprehensive regulatory matrices to classify marketplace products, addressing healthcare compliance across transportation, storage, resale, donation, and disposal operations, and supporting the development of Artificial Intelligence-based compliance tools.
• Advised an international alcoholic beverages company on the update of its sanitary registration portfolio before INVIMA, including importer changes, labeling reviews, and name modification filings to ensure business continuity.
• Advised a premium tequila producer on the filing and processing of a sanitary registration before INVIMA, aligning the regulatory strategy with the commercial launch of a high-profile brand in Colombia.
• Advised a food sector company on communications and filings before INVIMA related to labeling modifications, enabling uninterrupted commercialization and ensuring compliance with applicable healthcare regulations.
• Advised a multinational pharmaceutical logistics company on the regulatory framework applicable to the dispensing and delivery of medicines in Colombia, assessing compliance risks and mitigation strategies involving third parties.
• Conducted a comprehensive regulatory compliance assessment for a global veterinary genetic diagnostics company entering the Colombian market, addressing product classification, DNA sampling, labeling, and data protection matters.
• Issued key legal opinions to a food and beverage company regarding regulatory risks associated with front-of-package labeling and the implications of potential nutritional claims before INVIMA.
• Advised a leading food manufacturer in connection with an INVIMA administrative act ordering the modification of a product category in its sanitary registration, defining regulatory and response strategies.
• Advised an international airline on regulatory compliance for the transportation of human organs and tissues, including authorizations, ethical restrictions, documentation, and inter-institutional coordination.
• Advised an international medical devices manufacturer on the regulatory status of custom-made dental aligners in Colombia, including registration requirements, INVIMA challenges, and defense strategies.